Designer Drug Screening

Getting the most out of TOF-MS-based accurate mass screening of designer drugs

contributed by SCIEX | 08/22/2016

Adrian Michael Taylor – forensic technical specialist – presents advances in accurate mass screening of designer drugs with a focus on both hardware and software solutions. Adrian covers the importance of monitoring designer drugs, debates accurate mass versus nominal mass, and describes how both TOF-MS and TOF-MS/MS data can be acquired for all compounds – even unanticipated compounds – in a sample.

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.